BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/9/2026 4:15:47 AM | Browse: 1 | Download: 1
Publication Name World Journal of Gastroenterology
Manuscript ID 123681
Country China
Received
2026-05-26 06:05
Peer-Review Started
2026-05-26 06:06
First Decision by Editorial Office Director
Return for Revision
2026-07-31 02:06
Revised
2026-08-13 12:46
Publication Fee Transferred
2026-09-08 02:46
Second Decision by Editor
2026-10-08 07:09
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-10-08 09:04
Articles in Press
2026-10-08 09:04
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-10-23 09:23
Publish the Manuscript Online
2026-11-09 04:15
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cell & Tissue Engineering
Manuscript Type Review
Article Title Small extracellular vesicles as liquid biopsy targets and precision therapeutics for metabolic dysfunction-associated steatotic liver disease
Manuscript Source Unsolicited Manuscript
All Author List Ling-Ling Ding, Han Liu, Yang Yu, Xue-Chao Liu, Shu-Qin Zhang, Hui Qian and Dong-Lin Hao
ORCID
Author(s) ORCID Number
Ling-Ling Ding http://orcid.org/0000-0002-3343-4222
Hui Qian http://orcid.org/0000-0002-0098-3196
Funding Agency and Grant Number
Funding Agency Grant Number
the High-Level Talent Scientific Research Start-up Funding of Jiangsu University 5501280008
Jiangsu Province Double Innovation Doctoral Talent Program JSSCBS20221179
the China Postdoctoral Science Foundation 2023M741425
the Industry-University-Research Cooperation Project with Nanjing EVLiXiR 8411283025
Corresponding Author Ling-Ling Ding, Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, No. 2 Yongning North Road, Changzhou 213002, Jiangsu Province, China. l.ding@ujs.edu.cn
Key Words Metabolic dysfunction-associated steatotic liver disease; Small extracellular vesicles; Extracellular vesicles; Liquid biopsy; Biomarkers; Noninvasive tests; Drug delivery systems; Therapeutic strategies
Core Tip Metabolic dysfunction-associated steatotic liver disease (MASLD) lacks non-invasive biomarkers and targeted therapies. Small extracellular vesicles (sEVs) offer dual solutions: As diagnostic tools, sEV-derived miRNAs (e.g., miR-122), proteins (e.g., Kelch-like protein 41), and lipids enable accurate staging; as therapeutics, mesenchymal stem cell-derived sEVs reduce steatosis and fibrosis via autophagy and oxidative stress regulation, while engineered sEVs (e.g., cyclic arginine-glycine-aspartic acid-modified) enhance targeted delivery. sEVs thus shift from bystanders to key diagnostic and therapeutic players in MASLD.
Publish Date 2026-11-09 04:15
Citation

Ding LL, Liu H, Yu Y, Liu XC, Zhang SQ, Qian H, Hao DL. Small extracellular vesicles as liquid biopsy targets and precision therapeutics for metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2027; 33(1): 123681

URL https://www.wjgnet.com/1007-9327/full/v33/i1/123681.htm
DOI https://doi.org/10.3748/wjg.123681
Full Article (PDF) WJG-33-123681-with-cover.pdf